4-1BB与肿瘤特异性免疫治疗研究进展
4-1BB in tumor specific immunotherapy
摘要
4 1BB(CD13 7)是新近发现的一种新型共刺激分子 ,其单独作用 (抗 4 1BBMoAb或 4 1BBL)及联用其他共刺激分子 (如B7 1)或细胞因子 (如IL 12 )显示了强效的抗肿瘤作用 ,且联用较单用时更显著、持久。现主要从 4 1BBL、抗 4 1BB MoAb及联用B7 1、IL 12等方面作一综述。
出处
《国外医学(肿瘤学分册)》
CAS
2003年第5期342-344,共3页
Foreign Medical Sciences (Cancer Section)
参考文献12
-
1张利宁,赵文璞,曹英林,马春红,宋静,孙汶生.人CD137单抗诱导不同状态T细胞增殖和凋亡的研究[J].上海免疫学杂志,2000,20(2):77-80. 被引量:4
-
2Wilcox RA, Chapoval AI, Gorski KS, et al. Cutting edge: Expression of functional CD137 receptor by dendritic cells[J]. J Immunol, 2002, 168(9): 4262-4267.
-
3Wen T, Bukezynski J, Watts TH. 4-1BB ligand-mediated eostimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effeetor function [J]. J Immunol, 2002, 168(10): 4897-4906.
-
4Gramaglia I, Cooper D, Miner KT, et al. Co-stimulation of antigenspecific CD4 T cells by 4-1BB ligand[J]. Eur J Immunol, 2000, 30(2) : 392-402.
-
5Kim YJ, Broxmeyer HE. Therapeutic potential of 4-1BB(CD137) as a regulator for effector CDS( + ) T cells[J]. J Hematother Stem Cell Res, 2001, 10(4): 441-449.
-
6Wilcox RA, Tamada K, Strome SE, et al. Signaling through NK cell-assoceiated CD137 promotes both helper function for CDS( + ) cytolytie T cells and responsiveness to IL-2 but not cytolytie activity [J]. J Immunol, 2002, 169(8): 4230-4236.
-
7Wilcox RA, Flies DB, Zhu GF, et al. Provision of antigen and CD137 signaling breakes immunological ignorance, promoting regressionof poorly immunogenic tumors[J]. J Clin Invest, 2002, 109(5) : 651-659.
-
8Salih HR, Kosowski SG, Haluska VF, et al. Constitutive expression of functional 4-1BB(CD137) ligand on carcinoma cells[J]. J Immunol, 2000, 165(5): 2903-2910.
-
9Radhakrishnan S, Nguyen LT, Cirie B, et al. Naturally occurring human IgM antibody that binds 137-13(2 and potentiates T cell stimulation by dendritic celLs[J]. J Immunol, 2003, 170(4): 1830-1838.
-
10May KF Jr, Chen L, Zheng P, et al. Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of ttmmr specific CDS( + ) T cells[J]. Can cer Res, 2002, 62(12): 3459-3465.
共引文献3
-
1吴俊英,钱峰,吕合作,王伟.4-1BB在人外周血γδT细胞活化中的协同刺激作用[J].现代免疫学,2006,26(4):327-330.
-
2万兵,张利宁,马春红,宋静,曹英林,李长菲,孙汶生.人4-1BB-hIgG1Fc融合蛋白真核表达载体的构建[J].山东医科大学学报,2002,40(1):17-18. 被引量:1
-
3陈学鹏,彭晓.rIL-2、IFN-γ和胸腺肽对T细胞共刺激信号分子CD137表达的影响[J].中华微生物学和免疫学杂志,2003,23(9):721-722.
-
1张谷,陈玉心,敖忠芳.应用单克隆抗体(MoAb)对白血病免疫分型的临床研究[J].南京医学院学报,1992,12(2):132-135.
-
2陈斌,葛建文,储莉,康富标.原发性肝癌的免疫治疗进展[J].中华保健医学杂志,2010,12(3):233-234.
-
3陈海彬,周红光,吴勉华.树突状细胞与恶性肿瘤[J].辽宁中医药大学学报,2010,12(5):28-30.
-
4邹鸿志,郁宝铭.MAGE基因与肿瘤特异性免疫治疗[J].国外医学(肿瘤学分册),2000,27(5):274-276. 被引量:2
-
5代国知,袁红霞,陈虹亮.基于树突状细胞的肿瘤免疫治疗研究进展[J].现代肿瘤医学,2012,20(2):409-411. 被引量:10
-
6于江虹.开发来自外周血单核细胞的人DC疫苗[J].国外医学(输血及血液学分册),1998,21(4):246-247.
-
7蒋文军,卢绍平,魏阳,唐小兰,吴俊辉.新城鸡瘟病毒用于肿瘤特异性免疫治疗的研究进展[J].四川肿瘤防治,2003,16(1):60-61. 被引量:4
-
8时永全.热休克蛋白-多肽复合物诱导肿瘤特异性免疫的机理[J].细胞与分子免疫学杂志,1997,13(A02):58-60.
-
9王晓,李梁,冯凯,白慈贤,裴雪涛.HSV-tk基因在人乳腺癌细胞中的表达及其诱导杀伤的特性研究[J].中国肿瘤生物治疗杂志,2001,8(3):217-219.
-
10韩泽广,何徐彭,敖忠芳,陈玉心.过氧化物酶染色阴性的急性非淋巴细胞白血病免疫诊断特点及其临床意义[J].临床内科杂志,1994,11(5):30-31.